SecBot SecBot
Insider Cluster (7 insiders) ·Filed Mar 3, 2026

BLFS

BIOLIFE SOLUTIONS INC
BEARISH
Impact 6/10
Horizondays Processed8mo ago
Insider cluster: 6 insiders, $2.0M total
Actionable Insight ▼ Bearish

Monitor for potential downward pressure on the stock ahead of next earnings or any lack of positive catalysts; consider this cluster as a negative signal from top executives who may have visibility into near-term challenges.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$20.17
T+0 close · Mar 2, 2026 · via day close
Latest settled
+21.47%
T+60 · $24.50
Vs SPY
+11.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 3 $20.17entry
  2. T+1 · 9mo ago +2.48%α +1.72% · $20.67
  3. T+5 · 8mo ago −7.44%α −6.96% · $18.67
  4. T+20 · 8mo ago −5.40%α −1.00% · $19.08
  5. T+60 · 6mo ago +21.47%α +11.15% · $24.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple C-suite executives at BioLife Solutions sold shares in a coordinated cluster over the past week, with total open-market sales amounting to approximately $2.0 million. The majority of the activity was driven by Chief Quality and Operations Officer Karen Foster, who sold nearly $1.95 million worth of stock, representing the bulk of the insider activity.

Key Financial Metrics

Direction
selling
Total Value
$2.0M
Insiders
7

Key Facts

  • 7 open-market sales by C-suite executives over a 7-day period
  • Total value of sales: ~$2.0 million
  • Karen Foster (Chief Quality and Operations) sold 97,884 shares for ~$1.96 million
  • All transactions were open-market sales (S code), not forced or tax-related disposals
  • Sales represent ~0.21% of company's $959M market cap

Financial Impact

$2.0 million in insider sales over 7 days, representing 0.21% of market cap

insider sentimentownership concentrationinvestor confidence

Risk Factors

  • Insider selling could signal lack of confidence in near-term prospects
  • Potential for negative market perception leading to short-term price weakness

Market Snapshot

Exchange
Nasdaq

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (8 trades, 7d window)cluster-BLFS-1773094298667

Track record

15 reports on BLFS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry price pending
  2. Nov 6, 202610d ago Institutional Cluster Bearish 4/10 No price data
  3. Oct 27, 202620d ago SC 13G/A Neutral 3/10 No price data
  4. Oct 16, 20264w ago 15-12G Neutral 4/10 No price data
  5. Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
  6. Oct 13, 20264w ago EFFECT Neutral 3/10 No price data
  7. Oct 6, 20265w ago 8-K Bullish 7/10 Entry $39.00 No price data
  8. Sep 30, 20266w ago 425 Neutral 4/10 Entry $38.85 No price data
  9. Sep 30, 20266w ago DEFA14A Neutral 4/10 Entry $38.85 No price data
  10. Sep 24, 20267w ago SC 13G Neutral 4/10 Entry $38.58 No price data
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (12h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 9, 2026